Skip to main content

Please note: This page is intended for healthcare professionals only. It is designed as a general educational guide and does not replace local guidance, senior clinical advice, or individual clinical judgement. Patients should not use this page as medical advice and should seek advice from an appropriate healthcare professional.

Renal Tract Stones & Colic

Urinary tract stones are solid crystalline deposits that form when substances in urine precipitate and aggregate. Stone disease is common, and its complications are among the most frequent acute presentations managed by the on-call Urology SHO.

Stones may be non-obstructing within the kidney and asymptomatic, or may migrate into the ureter and cause obstruction, resulting in acute ureteric colic. Recognising the difference between an incidental renal stone, uncomplicated ureteric colic, and complicated obstruction is key to safe investigation and management.

EmergencyINFECTED OBSTRUCTED KIDNEY

Why this matters

  • An infected obstructed kidney is a urological emergency. It occurs when urine cannot drain from the kidney due to obstruction, and the obstructed system becomes infected.
  • Patients can deteriorate rapidly with urosepsis, AKI and septic shock — act quickly.
  • This is most commonly caused by an obstructing ureteric stone but can occur with any cause of urinary tract obstruction/hydronephrosis.
  • Do not treat with antibiotics alone. Patients need source control with urgent drainage of the obstructed kidney, usually by ureteric stent or percutaneous nephrostomy.

What to do now

  • Escalate to Urology SpR / consultant
  • Follow Sepsis 6 (see HERE) and resuscitate
  • Antibiotics as per local policy for sepsis of urinary tract
  • Monitor urine output – consider urethral catheter
  • Involve Critical Care / Outreach / ICU team. Consider need for HDU bed.
  • Keep NBM – in case patient needs to go to theatre

Investigations:

  • Bloods – FBC, U&Es, CRP, lactate, clotting +/- group and save
  • Imaging – to confirm diagnosis, usually CT KUB / AP
  • Send cultures – urine and blood (ideally before antibioitcs)
  • Urgent decompression / surgical source control nephrostomy or ureteric stent

Acute ureteric colic

Definition

Acute ureteric colic is a pain syndrome caused by partial or complete obstruction of the ureter, most commonly due to a migrating urinary stone. It represents the most frequent acute presentation of stone disease and is the principal cause of stone-related pain.

Note: It is important to be aware of your trust's local policies regarding when patients presenting with suspected acute ureteric colic should be seen by the on-call urology team. Local practice and referral criteria may vary between departments.

 
Clinical Presentation

Typical features include:

  • Sudden onset severe flank pain
  • Radiation to the groin or external genitalia (some present with only testicular pain)
  • Restlessness and inability to find a comfortable position
  • Nausea and vomiting
  • Lower urinary tract symptoms (LUTS) with distal ureteric stones
  • Visible or non-visible haematuria
    • Haematuria is common but absent in ~10% of CT-confirmed cases and should not exclude the diagnosis if clinical suspicion is high
  • Do not miss sepsis! If you suspect an infected obstructed kidney – it is a urological emergency!

Red Flags - Alternative Diagnosis

  • Haemodynamic instability
  • Generalised abdominal pain and guarding
  • Neurological deficits
  • Pain disproportionate to findings
 
Pathophysiology

Ureteric obstruction leads to:

  • Rapid rise in intraluminal pressure
  • Prostaglandin-mediated vasodilation and increased renal blood flow
  • Increased diuresis
  • Ureteric smooth muscle spasm
  • Activation of visceral afferent pain pathways
As a result, pain severity reflects the degree and acuteness of obstruction rather than stone size. This explains why small stones may cause severe pain, while larger stones may be painless if non-obstructing.
 
Differential diagnoses of “Flank pain”

Beware of the leaking aortic aneurysm, as it can mimic ureteric colic!

Red flags need to have FAST scan in A&E:

  • Male > 65yrs
  • Sudden severe pain in back and/or abdomen
  • Can have non-visible haematuria
  • Hypotension
  • Feeling cold, clammy, sweaty, faint and breathless
  • Loss of consciousness
  • Abdominal pulsatile mass
Leaking abdominal aortic aneurysm
Differentials for flank pain
 
Investigation
  • Urinalysis
    • May help with the diagnosis of a concurrent UTI alongside a urinary tract stone
      • Send a urine culture if infection suspected
    • The absence of haematuria does not exclude ureteric obstruction
  • Blood tests
    • Not diagnostic for stone disease, useful to assess for contributing factors and complications
    • U&Es – assess renal function and obstruction
    • Adjusted calcium – screen for hypercalcaemia/metabolic disease
    • Urate – high levels may suggest uric acid stones
    • FBC, CRP and VBG – required to assess infection markers and lactate and is necessary for pre-operative planning
    • INR – patient may require intervention (e.g., nephrostomy)
  • Imaging
    • Imaging should generally be performed within 24 hours unless urgent intervention is required
    • Low-dose non-contrast CT KUB – first-line in most adults (gold standard)
      • Sensitivity and specificity = 95–97%
      • Defines stone location, size, location, burden, obstruction and alternative diagnoses, detect complications
    • Plain X-ray KUB – not suitable for diagnosing, but may be useful for follow-up
      • The scout film performed before CT imaging can be used as a guide to see if the patient's stone can be seen on X-ray KUB
    • US KUB – can be useful in patients who aren't appropriate for CT as a screening tool (e.g., pregnant, women of fertile age)
      • Good for visualising renal stones and seeing hydronephrosis but can miss ureteric calculi
    • MRI / MRI urography – may be considered for patients who cannot have a CT and USS is insufficient to make a clinical decision (e.g. pregnant women)
 
Treatment

Indications for Admission

Admit urgently if any of the following are present:

  • Infected obstructed system (urological emergency)
  • Acute kidney injury (AKI) or rising creatinine
  • Intractable pain despite adequate oral/IV analgesia
  • Solitary obstructed kidney or bilateral ureteric stones
  • Ruptured calyx and urine leak
  • Pregnancy or significant comorbidity (case-by-case)
Principles of Management

Treatment depends on:

  • Stone size
  • Stone location (upper, mid, lower ureter / VUJ)
  • Symptoms and complications (infection, renal impairment)
  • Patient factors (single kidney, pregnancy, comorbidity)

Likelihood of Spontaneous Stone Passage (SSP)

Likelihood of Spontaneous Stone Passage (SSP). Evidence from the MIMIC study demonstrates that both stone size and location strongly influence SSP rates.

Approximate SSP rates (%):

Location <5 mm 5–7 mm >7 mm
Upper ureter ~71% ~26% ~14%
Mid ureter ~80% ~52% ~38%
Lower ureter / VUJ ~89% ~62% ~47%

Key message: Small stones and distal location have the highest likelihood of spontaneous passage.

MIMIC calculator: HERE

Reference: MIMIC Study (Multicentre Initiative for Urolithiasis Care)

Management Options
  • 1
    Analgesia
    • First-line treatment for all patients without immediate surgical indication
      • NSAIDs are first line – reduce ureteric smooth muscle spasm and prostaglandin-mediated pain
        • Best outcomes are via the PR route (e.g. Diclofenac 100mg STAT OR 50mg TDS, max 150mg/24hrs, 8hrly)
        • Avoid NSAIDs or use cautiously in significant AKI
      • Paracetamol
      • Opioids (e.g. morphine) if pain persists despite NSAIDs
      • Antiemetics (e.g. ondansetron, cyclizine) if required
  • 2
    Medical Expulsive Therapy (MET)
    • Alpha-blockers (e.g. tamsulosin 400 mcg) until stone passed or failure of conservative management
      • Practical tip – When discharging patient give prescription for 28 days
    • The evidence for MET is mixed, the strongest evidence supports their use in distal ureteric stones 5–10 mm.
  • 3
    Observation
    • Appropriate for: Clinically stable patients, No infection or renal impairment, Stones with reasonable likelihood of SSP
    • Duration: Typically up to 4 weeks, provided symptoms are controlled
    • Must-have follow-up: This usually involves repeat imaging, review of symptoms and renal function
    • If stone is still present after 4–6 weeks, then it is very unlikely to pass and will require intervention
  • 4
    Surgical Management

    Indicated if: Failure of conservative management, Ongoing pain, obstruction, or deterioration in renal function, Low likelihood of spontaneous passage

    • Ureteric stent: Emergency decompression (e.g. sepsis, AKI), doesn’t treat the stone. Will need to be booked for definitive stone treatment.
    • Nephrostomy insertion: Done by IR, but trusts may have very limited access to IR. Advantages – can be done under LA, shows urine output from the corresponding kidney, can be used as surgical access for future stone surgery.
    • Ureteroscopy (URS) + laser lithotripsy: Definitive treatment. Can be done at time of acute presentation or if failed MET.
    • Extracorporeal Shock Wave Lithotripsy (ESWL): Suitable for selected stones (size, density, stone-to-skin distance dependent)
 
Follow-up:

All patients need to have follow-up — see your local pathway for specifics, as this can vary!

  • 1
    Prescribe adequate analgesia - regular Paracetamol, PRN Dihydrocodeine + Diclofenac
  • 2
    MET – variable practice and depends on local policy – check with Urology SpR
  • 3
    Book imaging in 3-4 weeks
    • Modalities – CT KUB (limited pelvis if distal ureter /VUJ), XR KUB, USS KUB.
    • Choice depends on local practice
  • 4
    Follow-up with results. This can be done via:
    • Stone clinic
    • General Urology clinic
    • “Write with results”
 

Take home message

  • Renal stones are often asymptomatic
  • Pain occurs due to ureteric obstruction
  • Absence of haematuria does not exclude stones
  • CT KUB is the diagnostic gold standard
  • Stone size and location predict passage
  • Uric acid stones are the only stones that may dissolve
  • Infection plus obstruction is life-threatening
 

Renal stones

Overview
Struvite renal stone
  • Renal stones are frequently discovered incidentally on imaging.
  • Renal stones can be found in every part of the collecting system and can be obstructing and non-obstructing.
  • Very large stones are called:
    • Staghorn = stone occupying the renal pelvis and ALL major calyces
    • Partial staghorn = stone occupying the renal pelvis and one or more calyces (but not all)
  • Renal stones may remain asymptomatic, increase in size over time, migrate into the ureter, or predispose to infection or obstruction.
  • Importantly, the presence of a renal stone does not necessarily imply symptoms, and many stones remain clinically silent for long periods.
 
 
Epidemiology
  • Lifetime prevalence: Approximately 10–15% in men, 5–7% in women
  • Peak incidence occurs between 30 and 60 years of age
  • Recurrence is common: Around 30–50% of patients will form another stone within 5 years
  • The rising incidence is attributed to changes in diet, reduced fluid intake, obesity, metabolic syndrome, and environmental factors leading to dehydration
 
Pathophysiology

Stone formation is driven by urinary supersaturation with poorly soluble salts. Under normal conditions, urine contains inhibitors of crystal formation (such as citrate and magnesium) and sufficient volume to prevent crystallisation. Stone disease develops when these protective mechanisms are overwhelmed.

The process involves:

  • Supersaturation of urine with stone-forming substances
  • Crystal nucleation, often on renal papillae (Randall's plaques)
  • Crystal growth and aggregation
  • Retention of crystals within the kidney rather than washout

Promoting factors

  • Low urine volume
  • Abnormalities in calcium, oxalate, phosphate or uric acid handling
  • Altered urine pH
  • Genetic predisposition
  • Infections
  • Certain medications
 
Associated Conditions
Renal calculi
Renal calculi
  • Enteric disease or bowel resection (e.g. Crohn's) → hyperoxaluria
  • Primary hyperparathyroidism → hypercalciuria
  • Distal (type 1) renal tubular acidosis → alkaline urine, Ca phosphate stones
  • Gout / metabolic syndrome → acidic urine, uric acid stones
  • Recurrent UTI → struvite stones
 
 
Types of urinary tract stones

Stone composition is clinically relevant because it influences recurrence risk, prevention strategies, and treatment response. It is important to remember that stones can often have mixed composition.

Read more here

Calcium Stones (~70–80%)

Calcium stones are the most common renal stones. They form when calcium combines with oxalate or phosphate in urine.

Calcium oxalate (~60-70%)

Most common stone type overall. Associated with low urine volume, hypercalciuria, hyperoxaluria, and hypocitraturia. Can form across a wide urine pH range. Often recurrent, generally responsive to ESWL. Prevention focuses on hydration, dietary sodium and oxalate reduction, and increased citrate intake where indicated.

Calcium phosphate (~10-15%)

Form preferentially in alkaline urine. Suggest abnormalities of urinary acidification.

Subtypes include: Carbonate apatite (~8-12%): more common, often infection-associated, moderate hardness; Brushite (~1-2%): hard, dense, recurrent, poor ESWL response. Associated with distal (Type 1) renal tubular acidosis, hypercalciuria, and carbonic anhydrase inhibitors (e.g. topiramate).

Uric Acid Stones (~10%)

The only common stone type that can be treated without surgery. Form in persistently acidic urine. Associated with gout, metabolic syndrome, chronic diarrhoea, and low urine volume. Radiolucent on plain X-ray, visible on CT. Can dissolve with sustained urine alkalinisation.

Infection (Struvite) Stones (~5-10%)

Stones caused by infection rather than metabolic imbalance. Form in alkaline urine due to urease-producing bacteria. Grow rapidly and may form staghorn calculi. Act as a reservoir for infection. More common in women, chronic infections, neurogenic bladder.

👉 Antibiotics alone are insufficient; complete surgical clearance is required.

Cystine Stones (Rare) (~1-2%)

Caused by inherited cystinuria. Present early in life. Highly recurrent and often ESWL-resistant.

👉 Lifelong condition requiring specialist follow-up.

Other and Uncommon Stone Types

Drug-related stones: Direct crystallisation (indinavir, atazanavir, triamterene, sulfonamides) Drug-induced metabolic effects (topiramate, acetazolamide → alkaline urine, hypocitraturia → ↑ calcium phosphate stones).

Matrix stones: Soft, protein-rich, poorly calcified, often associated with chronic infection or catheters.

Rare metabolic stones: Xanthine stones (xanthinuria), 2,8-dihydroxyadenine stones (APRT deficiency; risk of progressive renal impairment, respond to allopurinol).

👉 Always review medication history in recurrent or atypical stone disease.

 
 
Investigation
  • Imaging is central to diagnosis and assessment
    • Non-contrast CT KUB – gold standard. Sensitivity/specificity: ~95–97%. Defines stone size, location, burden, obstruction, and alternative diagnoses. Stone radiodensity (Hounsfield units (HU)) is associated with stone composition and hardness.
    • Ultrasound – adjunctive, useful for surveillance. Sensitivity: ~45–60% (lower for ureteric stones), Specificity: ~85–90%. Preferred in pregnancy and selected younger patients. May incidentally find stones and justify performing CT KUB.
    • Plain X-ray KUB – limited role. Sensitivity: ~40–60%, Specificity: ~70–80%. Not for initial diagnosis; used for follow-up of known radiopaque stones, particularly post-ESWL.
    • MRI KUB – not first line for stone. Limited role in specific cases. May be indicated for those who cannot have a CT and USS insufficient.
  • Blood tests and urinalysis
    • Should be performed as described above in the acute ureteric colic section
      • FBC, U&E's, calcium and urate, clotting
    • All patients require a mid-stream urine culture prior to undergoing definitive stone surgery
  • Stone analysis
    • Should be performed whenever a stone is retrieved, as composition guides recurrence prevention
  • 24-hour urine metabolic evaluation
    • Indicated in recurrent or high-risk stone formers
    • Used for prevention rather than acute diagnosis
 
Management of Renal Stones

Management depends on stone size, location, symptoms, and patient factors. Options fall into observation, active treatment, and prevention, which may be used alone or in combination over time. Stone prevention advice is important.

The treatment decisions for complex stones is often determined in the urology stone MDT.

  • 1
    Observation
    • Surveillance with interval imaging. Used as part of ongoing management in selected patients. Strategy may change depending on stone behaviour and clinical context.
  • 2
    Active Treatment
    • Shockwave lithotripsy (ESWL)
    • Ureteroscopy + laser lithotripsy (URS)
    • Percutaneous nephrolithotomy (PCNL) – reserved for larger or complex stone
  • 3
    Medical dissolution
    • Applicable to majority of uric acid stones only
    • Achieved through urine alkalinisation
    • Agents include potassium citrate or sodium bicarbonate
    • Requires urine pH monitoring and radiological follow-up
  • 4
    Targeted metabolic treatment
    • Used to modify identified metabolic risk factors
    • May include: Citrate-based therapy, Allopurinol (in patients with hyperuricosuria or uric acid stone disease), Thiazide diuretics (to reduce urinary calcium excretion), Thiol-binding drugs and captopril (for cysteinuria patients), Stone-specific dietary measures
    • Guided by stone analysis and/or metabolic evaluation
 
Prevention
  • Adequate fluid intake
  • Stone dietary advice such as BAUS diet leaflet HERE
  • Stone-specific preventive strategies guided by composition and metabolic assessment, particularly in recurrent or high-risk stone formers
  • Prevention of UTI's
 

References

  1. National Institute for Health and Care Excellence (NICE). Renal and ureteric stones: assessment and management (NG118). 2019.
  2. European Association of Urology. EAU Guidelines on Urolithiasis. 2025.
  3. Tsiotras A, Smith RD, Pearce I, O'Flynn K, Wiseman OJ. BAUS standards for management of acute ureteric colic. J Clin Urol. 2018;11:58–61.
  4. Shah TT, Gao C, Peters M, et al. Factors associated with spontaneous stone passage (MIMIC study). BJU Int. 2019;124:504–513.
  5. Pickard R, Starr K, MacLennan G, et al. Medical expulsive therapy in ureteric colic (SUSPEND). Lancet. 2015;386:341–349.
  6. BAUS Patient Information - Kidney Stones